Cargando…
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors
The receptor tyrosine kinase MET and its ligand, the Hepatocyte Growth Factor/Scattor Factor (HGF/SF), are essential to the migration, morphogenesis, and survival of epithelial cells. In addition, dysregulation of MET signaling has been shown to promote tumor progression and invasion in many cancers...
Autores principales: | Mekki, Meriem Sarah, Mougel, Alexandra, Vinchent, Audrey, Paquet, Charlotte, Copin, Marie-Christine, Leroy, Catherine, Kherrouche, Zoulika, Bonte, Jean-Paul, Melnyk, Oleg, Vicogne, Jérôme, Tulasne, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007473/ https://www.ncbi.nlm.nih.gov/pubmed/29930749 http://dx.doi.org/10.18632/oncotarget.25472 |
Ejemplares similares
-
MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering
por: Montagne, Rémi, et al.
Publicado: (2017) -
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist
por: Simonneau, Claire, et al.
Publicado: (2015) -
Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors
por: Baldacci, Simon, et al.
Publicado: (2017) -
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)‐dependent oncogenic driver in vitro and in humanised HGF knock‐in mice
por: Fernandes, Marie, et al.
Publicado: (2023) -
Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity
por: Lefebvre, J, et al.
Publicado: (2013)